Prof. Dr. med. Carola Berking

Lehrstuhl für Haut- und Geschlechtskrankheiten

International real-world study of combination immunotherapy sequences in metastatic melanoma. (2025) Guardamagna M, Lochrin SE, Smithy JW, Postow M, Gaudy-Marqueste C, Malissen N, Monestier S, et al. Journal article Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8 (2025) Koch E, Liguori R, Castro AA, Schliep S, Petzold A, Wessely A, Fröhlich W, et al. Journal article Machine learning model to classify chronic leg wounds and identify pyoderma gangrenosum (2025) Busch DA, Richter ML, Hüsers J, Przysucha M, Kücking F, Mang JM, Moelleken M, et al. Journal article SOX10, MITF, and microRNAs: Decoding their interplay in regulating melanoma plasticity (2025) Lai X, Luan C, Zhang Z, Wessely A, Heppt M, Berking C, Vera J Journal article, Review article An artificial intelligence model of whole-slide pathology specimens differentiating cutaneous high-grade squamous proliferations (2025) Petzold A, Wessely A, Erdmann M, Schliep S, Schreml S, Rivera Monroy LC, Vera J, et al. Journal article Sex-specific survival in advanced metastatic melanoma – a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG (2025) Leven AS, Peters T, Rajcsanyi LS, Weichenthal M, Mohr P, Meier F, von Wasielewski I, et al. Journal article CD163/CD63+ Monocyte-Derived DC Profiled in Tissue by Multi-Antigen Analysis (MAA) Discriminate Chronic Eczema and Psoriasis (2025) Windorfer S, Kirr M, Fröhlich W, Plosnita B, Ostalecki C, Berking C, Sticherling M, Baur A Journal article Enhanced diagnostic potential of CSPG4 in melanoma and nevi: a comparative study with PRAME, CDC7 and Ki67 (2025) Koch E, Seidel C, Erber R, Erdmann M, Heppt M, Schliep S, Berking C, et al. Journal article Actinic Cheilitis: A Systematic Review and Meta-Analysis of Interventions, Treatment Outcomes, and Adverse Events (2025) Al-Fartwsi M, Petzold A, Steeb T, Djawher L, Wessely A, Leppert A, Berking C, Heppt M Journal article, Review article Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinoma. (2025) DeTemple VK, Kaatz M, Stockfleth E, Scheel C, Angela Y, Gutzmer R, Leiter U, et al. Journal article